back to home
Restricted area
CONTENTS
ABOUT WELCARE
 
HOME ABOUT US CLEANSING OTHER PRODUCTS
       
ABOUT US

WELCARE INDUSTRIES SPA

Welcare Industries is a manufacturing and distribution Company based in Orvieto, Italy. The Company focuses on hospital infection prevention and control and has developed a very unique and complete line of disposable Total Body Cleansing Washcloths (Medical Devices Class I) and an exclusive product range of disposable Wound and Skin Cleansing Washcloths (Medical Devices Class IIa).
The exclusive, disposable Wound and Skin Cleansing devices (Medical Devices class IIa - pre-moistened washcloths or gloves) are non allergenic and suitable for total body cleansing, including wounds, eyes, mucosal membranes.

Welcare’s Wound and Skin Cleansing washcloths are the only products available in Europe to be approved as Class IIa Medical Devices and the only products manufactured in clean rooms Class ISO 8 in accordance with GMPs.

The Company is certified:

UNI CEI ISO 13485:2004
UNI CEI EN ISO 14971:2007
ISO 9001:2008 AND ISO 9000:2005
UNI EN 980:2004
UNI EN 10993-I

Welcare Industries develops their products in collaboration with universities and research companies from around the world to assure to be always at the forefront of medical device technology in infection prevention and control, especially as it pertains to the nursing care segment.

Welcare Industries develops their products in collaboration with universities and research companies from around the world to assure to be always at the forefront of medical device technology in infection prevention and control, especially as it pertains to the nursing care segment.
In the utmost respect for the environment, Welcare Industries manufactures the devices reducing or eliminating synthetic components and eliminating ingredients that during the manufacturing process of during usage or disposal might release toxic compounds in the ecosystem, or components that would require special treatment in order to be disposed.
The Company prefers to use components whose supply sources are as close as possible to the production site in order to reduce transports and, thus, the emission of CO2 into the atmosphere.

As the multinational companies, Welcare has:

  • Attention to innovation
  • Knowledge of international demand
  • Internal key competences
  • Attention to quality control
  • Research capabilities
  • Relations with key hospital centers
  • Financial controls and transparency

As the small size companies, Welcare has:

  • Speed of response
  • Production flexibility
  • Quick time to market

Welcare’s main proprietary product lines are :

  • Wound and Skin Cleansing System portfolio for critical and chronic patients.
  • Total Body Cleansing portfolio for patients with fragile skin
  • Total Body Cleansing System for patients affected by MDROs
  • Cleansing and dressing system for acute and chronic wounds
  • Disposable Patient Eye Protection Masks for Surgery (Optigard™)
  • Personal Protection Devices for the medical and nursing staff
  • Sterile and non sterile non woven products (drapes and garments
  •  

    Company Management

    Franco Bernardini
    Founder & President
    MBA in Biology, University of Rome. Score 110 Cum Laude
    27 year experience in the medical device business;
    Senior management positions in major multinational companies: Roche, Acraf Angelini, Sherwood Medical
    Previous role: Managing Director Sherwood Medical Italy

    Fulvia Lazzarotto
    Partner and Managing Director

    MBA in Finance, Boston University, USA;
    14 year international experience in the medical device business;
    Senior management positions in major multinational companies : Hewlett Packard, Johnson & Johnson, Sherwood Medical, Bristol-Myers Squibb;
    Previous role: Vice President South Europe – Convatec, Bristol Myers Squibb

    Neal Koller
    Partner

    25 year career in life science where he has distinguished successes in both entrepreneurial and corporate responsibilities;
    Executive positions in multinational companies: Wyeth Pharmaceuticals, Sound Diagnostics, Dovetail Technologies;
    Served as President and Executive Committee Member of PDA, the prestigious global regulatory and manufacturing Bio/Pharmaceutical industry organization;
    Current role: President & CEO of Plurogen Therapeutics, Inc.

    European presence

    Welcare’s portfolio is available, through a distribution network, in Spain, Germany, Austria, Switzerland, Norway, Sweden, Finland, Lithuania, Estonia, Latvia, Turkey and Israel. Other markets are under expansion.